Credit Suisse Group AG restated their hold rating on shares of Humana Inc. (NYSE:HUM) in a research note issued to investors on Tuesday. They currently have a $188.00 target price on the insurance provider’s stock.

A number of other equities research analysts have also commented on HUM. Argus restated a hold rating on shares of Humana in a report on Tuesday, August 23rd. Cantor Fitzgerald restated a buy rating on shares of Humana in a report on Monday, August 8th. Jefferies Group dropped their price objective on shares of Humana from $220.00 to $217.00 and set a buy rating on the stock in a report on Thursday, August 4th. Barclays PLC dropped their price objective on shares of Humana from $193.00 to $191.00 and set an equal weight rating on the stock in a report on Thursday, August 4th. Finally, Zacks Investment Research upgraded shares of Humana from a hold rating to a buy rating and set a $197.00 price objective on the stock in a report on Monday, July 25th. Five research analysts have rated the stock with a hold rating and nine have given a buy rating to the company. Humana currently has an average rating of Buy and a consensus price target of $201.00.

Shares of Humana (NYSE:HUM) opened at 174.62 on Tuesday. The company’s 50-day moving average price is $176.84 and its 200 day moving average price is $176.92. The company has a market cap of $26.03 billion, a PE ratio of 26.83 and a beta of 0.91. Humana has a one year low of $150.00 and a one year high of $191.65.

Humana (NYSE:HUM) last posted its earnings results on Wednesday, August 3rd. The insurance provider reported $2.30 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $2.23 by $0.07. The company had revenue of $14 billion for the quarter, compared to analyst estimates of $13.59 billion. Humana had a net margin of 1.76% and a return on equity of 11.11%. The business’s revenue for the quarter was up 2.0% compared to the same quarter last year. During the same period last year, the business posted $1.67 earnings per share. Equities analysts forecast that Humana will post $9.26 EPS for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Friday, October 28th. Investors of record on Thursday, October 13th will be issued a dividend of $0.29 per share. This represents a $1.16 annualized dividend and a dividend yield of 0.66%. The ex-dividend date of this dividend is Tuesday, October 11th. Humana’s payout ratio is 18.18%.

Several hedge funds have recently made changes to their positions in the company. Aperio Group LLC increased its stake in shares of Humana by 16.6% in the first quarter. Aperio Group LLC now owns 63,470 shares of the insurance provider’s stock valued at $11,612,000 after buying an additional 9,052 shares during the last quarter. Commonwealth Equity Services Inc increased its stake in shares of Humana by 0.9% in the first quarter. Commonwealth Equity Services Inc now owns 3,694 shares of the insurance provider’s stock valued at $676,000 after buying an additional 33 shares during the last quarter. Factory Mutual Insurance Co. bought a new stake in shares of Humana during the first quarter valued at approximately $1,720,000. Sii Investments Inc. WI bought a new stake in shares of Humana during the first quarter valued at approximately $299,000. Finally, Cohen Lawrence B increased its stake in shares of Humana by 28.7% in the first quarter. Cohen Lawrence B now owns 4,332 shares of the insurance provider’s stock valued at $793,000 after buying an additional 966 shares during the last quarter. 93.37% of the stock is owned by institutional investors and hedge funds.

Humana Company Profile

Humana Inc is a health and well-being company. The Company’s segments include Retail, Group, Healthcare Services and Other Businesses. The Retail segment consists of Medicare benefits, marketed to individuals or directly via group accounts, as well as individual commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.

5 Day Chart for NYSE:HUM

Receive News & Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.